These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34382142)

  • 1. Metal Ion Interactions with mAbs: Part 2. Zinc-Mediated Aggregation of IgG1 Monoclonal Antibodies.
    Mehta S; Flores H; Walters B; Sreedhara A
    Pharm Res; 2021 Aug; 38(8):1387-1395. PubMed ID: 34382142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical and biological impact of metal-catalyzed oxidation of IgG1 monoclonal antibodies and antibody-drug conjugates via reactive oxygen species.
    Glover ZK; Wecksler A; Aryal B; Mehta S; Pegues M; Chan W; Lehtimaki M; Luo A; Sreedhara A; Rao VA
    MAbs; 2022; 14(1):2122957. PubMed ID: 36151884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular computations of preferential interactions of proline, arginine.HCl, and NaCl with IgG1 antibodies and their impact on aggregation and viscosity.
    Cloutier TK; Sudrik C; Mody N; Hasige SA; Trout BL
    MAbs; 2020; 12(1):1816312. PubMed ID: 32938318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity.
    Arora J; Hu Y; Esfandiary R; Sathish HA; Bishop SM; Joshi SB; Middaugh CR; Volkin DB; Weis DD
    MAbs; 2016; 8(8):1561-1574. PubMed ID: 27560842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of monoclonal antibodies at high-concentration: head-to-head comparison of the IgG1 and IgG4 subclass.
    Neergaard MS; Nielsen AD; Parshad H; Van De Weert M
    J Pharm Sci; 2014 Jan; 103(1):115-27. PubMed ID: 24282022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical and Biophysical Characteristics of Monoclonal Antibody Solutions Containing Aggregates Formed during Metal Catalyzed Oxidation.
    Narhi LO; Luo Q; Wypych J; Torosantucci R; Hawe A; Fujimori K; Nashed-Samuel Y; Jawa V; Joubert MK; Jiskoot W
    Pharm Res; 2017 Dec; 34(12):2817-2828. PubMed ID: 29110285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of monoclonal antibodies, IgG1, from cell culture supernatant by use of metal chelate convective interaction media monolithic columns.
    Rajak P; Vijayalakshmi MA; Jayaprakash NS
    Biomed Chromatogr; 2012 Dec; 26(12):1488-93. PubMed ID: 22362585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal ion interactions with mAbs: Part 1.
    Glover ZK; Basa L; Moore B; Laurence JS; Sreedhara A
    MAbs; 2015; 7(5):901-11. PubMed ID: 26121230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetate- and Citrate-Specific Ion Effects on Unfolding and Temperature-Dependent Aggregation Rates of Anti-Streptavidin IgG1.
    Barnett GV; Razinkov VI; Kerwin BA; Hillsley A; Roberts CJ
    J Pharm Sci; 2016 Mar; 105(3):1066-73. PubMed ID: 26886346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Computations of Preferential Interaction Coefficients of IgG1 Monoclonal Antibodies with Sorbitol, Sucrose, and Trehalose and the Impact of These Excipients on Aggregation and Viscosity.
    Cloutier T; Sudrik C; Mody N; Sathish HA; Trout BL
    Mol Pharm; 2019 Aug; 16(8):3657-3664. PubMed ID: 31276620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggregation Kinetics for IgG1-Based Monoclonal Antibody Therapeutics.
    Singla A; Bansal R; Joshi V; Rathore AS
    AAPS J; 2016 May; 18(3):689-702. PubMed ID: 26902302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viscosity of high concentration protein formulations of monoclonal antibodies of the IgG1 and IgG4 subclass - prediction of viscosity through protein-protein interaction measurements.
    Neergaard MS; Kalonia DS; Parshad H; Nielsen AD; Møller EH; van de Weert M
    Eur J Pharm Sci; 2013 Jun; 49(3):400-10. PubMed ID: 23624326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Increased Aggregation Propensity of a Light-Exposed IgG1 Monoclonal Antibody Using Hydrogen Exchange Mass Spectrometry, Biophysical Characterization, and Structural Analysis.
    Bommana R; Chai Q; Schöneich C; Weiss WF; Majumdar R
    J Pharm Sci; 2018 Jun; 107(6):1498-1511. PubMed ID: 29408480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Native Reversible Self-Association of a Monoclonal Antibody Mediated by Fab-Fab Interaction.
    Gentiluomo L; Roessner D; Streicher W; Mahapatra S; Harris P; Frieß W
    J Pharm Sci; 2020 Jan; 109(1):443-451. PubMed ID: 31563513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.
    Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Volkin DB; Weis DD
    MAbs; 2015; 7(1):84-95. PubMed ID: 25524268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of metal ions with tau protein. The case for a metal-mediated tau aggregation.
    Ahmadi S; Zhu S; Sharma R; Wilson DJ; Kraatz HB
    J Inorg Biochem; 2019 May; 194():44-51. PubMed ID: 30826589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing Conformational Diversity of Fc Domains in Aggregation-Prone Monoclonal Antibodies.
    Majumder S; Jones MT; Kimmel M; Alphonse Ignatius A
    Pharm Res; 2018 Sep; 35(11):220. PubMed ID: 30255351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregation mechanism of an IgG2 and two IgG1 monoclonal antibodies at low pH: from oligomers to larger aggregates.
    Arosio P; Rima S; Morbidelli M
    Pharm Res; 2013 Mar; 30(3):641-54. PubMed ID: 23054090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using extensional flow to reveal diverse aggregation landscapes for three IgG1 molecules.
    Willis LF; Kumar A; Dobson J; Bond NJ; Lowe D; Turner R; Radford SE; Kapur N; Brockwell DJ
    Biotechnol Bioeng; 2018 May; 115(5):1216-1225. PubMed ID: 29315487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Antibodies Follow Distinct Aggregation Pathways During Production-Relevant Acidic Incubation and Neutralization.
    Skamris T; Tian X; Thorolfsson M; Karkov HS; Rasmussen HB; Langkilde AE; Vestergaard B
    Pharm Res; 2016 Mar; 33(3):716-28. PubMed ID: 26563206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.